New pill aims to tame painful lupus skin flares in major trial
NCT ID NCT07332481
Summary
This study is testing whether a new pill called enpatoran can safely reduce the severity of skin rashes caused by lupus. About 202 adults with active lupus skin symptoms, with or without other body-wide lupus disease, will take either the study pill or a placebo for 24 weeks while continuing their standard lupus care. Researchers will measure changes in skin redness, scaling, hair loss, and itch to see if the new treatment helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Billerica, Massachusetts, 01821, United States
Conditions
Explore the condition pages connected to this study.